Check-Cap (NASDAQ:CHEK) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK) in a report issued on Wednesday morning. The firm issued a sell rating on the medical research company’s stock.

Check-Cap Stock Up 1.3 %

Shares of Check-Cap stock opened at $0.81 on Wednesday. Check-Cap has a twelve month low of $0.56 and a twelve month high of $3.04. The business has a 50-day moving average price of $0.87 and a 200-day moving average price of $1.07. The firm has a market cap of $4.74 million, a price-to-earnings ratio of -0.27 and a beta of 0.19.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.